Teva Pharmaceutical Industries Limited Earnings Preview: Get Ahead of the Analysts

Teva Pharmaceutical Industries Limited (NASDAQ:TEVA) will report earnings before markets open on Thursday, May 2nd. Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.

Here is your Cheat Sheet to Teva Pharmaceutical Industries Limited Earnings:

Earnings Expectations: Analysts expect earnings of $1.10 per share on revenues of $4.85 billion. Currently, the company’s P/E ratio stands at 17.00.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $1.22 to a profit $1.21. For the current year, the average estimate is a profit of $5.05, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Teva Pharmaceutical Industries Limited has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 11,080 13,900 16,120 18,310 20,320
Diluted EPS ($) 0.78 2.23 3.67 3.09 2.25

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 5,676 5,102 4,994 4,972 5,249
Diluted EPS ($) 0.5724 0.97 0.99 -0.09 0.3682

Past Performance:
Teva Pharmaceutical Industries Limited has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]